News
The company announced receiving CE Mark Certification in Europe for its HFX iQ spinal cord stimulation system. Nevro raised its 2024 adjusted EBITDA loss guidance to $18 million-$16 million from its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback